Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2020 | Story Leonie Bolleurs | Photo Anja Aucamp
Every year, several of our staff and students are involved in projects in our community to make a positive difference. One of the projects where we are making a difference is at Bloemshelter.

I am because you are. Ubuntu. What better month do we have to celebrate our Ubuntu, our South Africanness, than September – Heritage Month. 

South Africans are known for their warm and generous spirit, their humanity. Closer to home, here at the University of the Free State, this is also a reality. 

Bettering the lives of others

Numerous staff members and students engage in community projects and partnerships. “As a regionally engaged university, the UFS supports development and social justice through the practice of engaged scholarship,” says Karen Venter, Head of the Division: Service Learning within the Directorate of Community Engagement.

Engaged scholarship occurs at the heart of community-university partnerships in close and co-operative interaction with several organisations in broader society for the common public good.

A few of the flagship partnership projects that come to mind are Bloemshelter (caring for the homeless and developing as a social enterprise); Towers of Hope (caring for the vulnerable and transforming the city); and the Princess Gabo Foundation (in Thaba ‘Nchu, where they obtained a zero teenage pregnancy rate in school with a simulating doll-parenting programme to initiate responsible reproductive health education). 

In Qwaqwa, Community Engagement partnerships involve the Itemoheleng Soy Project and the AGAPE Foundation for Community Development. Here, the development focuses on nutrition to boost people’s immune systems – especially during the COVID-19 pandemic. According to Moodi Matsoso from the Directorate: Community Engagement on our Qwaqwa Campus, the AGAPE Foundation is manufacturing rosehip juice, which helps with digestion and the healing of ulcers. 

Bishop Billyboy Ramahlele, Director of Community Engagement, is also passionate about sharing knowledge and skills regarding enterprise development to others, supporting them to reach their full potential with the building of tiny houses. 

According to him, an estimated 3 000 of our students are spending at least 127 000 hours per year engaging in the community through 73 academic service-learning modules, excluding the engagement of student organisations such as the Enactus UFS and co-curricular KOVSIE ACT (Active Civic Teaching) residential schools projects.

Vegetables for the food insecure

Another project that is making a difference not only in the lives of our students, but also for food-insecure families, is the UFS Community Garden Project. 

Kovsie ACT, in collaboration with Student Affairs and the university’s Centre for Sustainable Agriculture, Rural Development and Extension (CENSARDE), is running a project where they provide fresh vegetables, including cabbage, carrots, beetroot, kale, and peas to food-insecure families. 

Heritage Month is an ideal opportunity for everyone to show their Ubuntu spirit. Get involved and share some of your time, your talents, and your treasures to improve the lives of others.  There are several causes in Bloemfontein and Phuthaditjhaba that need support (clothes, food, blankets, toys, funding). 

You saw what some of our colleagues and students are doing. What are you doing to make a difference in communities?

- See Mandala Day poster for a complete list of the partnerships, programmes, and projects where our university’s Directorate of Community Engagement is making a difference. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept